Table 3.
Position | Location | Mutation | 01/19/2020–01/20/2021 | |
---|---|---|---|---|
Total Count | Percentage | |||
66nt | 5´UTR | C → T | 2,787 | 3.9 |
204nt | G → T | 20,770 | 29.07 | |
241nt | C → T | 69,160 | 96.81 | |
445nt | ORF1ab polyprotein → leader protein | T → C | 34,505 | 48.3 |
1,163nt | nsp2 | A → T | 2,544 | 3.56 |
1,210nt | G → T | 1,440 | 2.02 | |
1,513nt | C → T | 1,528 | 2.14 | |
1,947nt | T → C | 1,576 | 2.21 | |
1,987nt | A → G | 3,018 | 4.22 | |
3,037nt | nsp3 | C → T | 69,231 | 96.91 |
3,256nt | T → C | 2,523 | 3.53 | |
4,002nt | C → T | 1,519 | 2.13 | |
4,543nt | C → T | 1,516 | 2.12 | |
6,286nt | C → T | 34,650 | 48.5 | |
6,807nt | C → T | 2,220 | 3.11 | |
7,528nt | C → T | 1,524 | 2.13 | |
7,926nt | C → T | 2,818 | 3.94 | |
8,683nt | nsp4 | C → T | 2,189 | 3.06 |
9,745nt | C → T | 3,640 | 5.1 | |
9,802nt | G → T | 1,449 | 2.03 | |
10,097nt | 3C‐like proteinase | G → A | 2,954 | 4.13 |
10,870nt | G → T | 3,186 | 4.46 | |
11,083nt | nsp6 | G → T | 5,734 | 8.03 |
11,396nt | C → T | 2,286 | 3.2 | |
11,533nt | A → G | 1,960 | 2.74 | |
11,781nt | A → G | 2,368 | 3.31 | |
12,067nt | nsp7 | G → T | 1,709 | 2.39 |
13,536nt | RNA‐dependent RNA polymerase | C → T | 1,502 | 2.1 |
14,202nt | G → T | 2,522 | 3.53 | |
14,408nt | C → T | 69,237 | 96.92 | |
14,805nt | C → T | 1,860 | 2.6 | |
15,406nt | G → T | 2,077 | 2.91 | |
18,877nt | 3'‐to‐5' exonuclease | C → T | 3,827 | 5.36 |
19,542nt | G → T | 2,582 | 3.61 | |
19,718nt | endoRNAse | C → T | 2,645 | 3.7 |
20,268nt | A → G | 1,999 | 2.8 | |
21,255nt | 2'‐O‐ribose methyltransferase | G → C | 34,494 | 48.28 |
21,575nt | Spike glycoprotein | C → T | 1,502 | 2.1 |
21,614nt | C → T | 17,561 | 24.58 | |
21,637nt | C → T | 2,697 | 3.78 | |
22,227nt | C → T | 34,855 | 48.79 | |
22,346nt | G → T | 2,244 | 3.14 | |
22,377nt | C → T | 1,518 | 2.12 | |
22,388nt | C → T | 2,540 | 3.56 | |
22,444nt | C → T | 2,085 | 2.92 | |
22,992nt | G → A | 1,636 | 2.29 | |
23,403nt | A → G | 69,262 | 96.95 | |
23,731nt | C → T | 2,940 | 4.12 | |
24,334nt | C → T | 10,442 | 14.62 | |
25,563nt | ORF3a | G → T | 5,774 | 8.08 |
25,614nt | C → T | 2,737 | 3.83 | |
26,060nt | C → T | 2,632 | 3.68 | |
26,144nt | G → T | 1,748 | 2.45 | |
26,424nt | Envelope protein | T → C | 1,957 | 2.74 |
26,735nt | Membrane glycoprotein | C → T | 3,760 | 5.26 |
26,801nt | C → G | 34,459 | 48.24 | |
27,769nt | ORF7b | C → T | 2,706 | 3.79 |
27,944nt | ORF8 | C → T | 25,177 | 35.24 |
28,169nt | A → G | 2,693 | 3.77 | |
28,854nt | Nucleocapsid phosphoprotein | C → T | 3,683 | 5.16 |
28,881nt | G → A | 23,975 | 33.56 | |
28,882nt | G → A | 23,947 | 33.52 | |
28,883nt | G → C | 23,946 | 33.52 | |
28,932nt | C → T | 34,536 | 48.34 | |
29,227nt | G → T | 2,566 | 3.59 | |
29,366nt | C → T | 1,743 | 2.44 | |
29,466nt | C → T | 2,578 | 3.61 | |
29,555nt | At upstream downstream region of ORF10 ORF9 | C → T | 1,466 | 2.05 |
29,645nt | ORF10 | G → T | 34,684 | 48.55 |
29,771nt | 3´UTR | A → G | 2,475 | 3.46 |
Details of the mutant analyses of 7,144 SARS‐CoV‐2 isolates for deviations from the Wuhan reference sequence. These sequences were deposited in the GISAID initiative between 01/19/2020 and 01/20/2021. For design of Tables, see legend to Table 5.